Children with epilepsies reportedly deriving benefits from medical marijuana (or cannabis-based medicinal products) accessed abroad and the UK government has allowed clinicians to prescribe these products.
A review published in Developmental Medicine & Child Neurology explores the science behind cannabis-based medicinal products in pediatric epilepsies and highlights areas that warrant additional research.
‘Licensed cannabis-based products can be used in childhood epilepsy with a proper regulatory system.’
READ RELATED: Coronavirus CAN enter the body through the eyes
The authors also examined the prescribing environment surrounding these products. They found that a lack of quality evidence for efficacy and safety is the major obstacle to prescribing.
Advertisement
They stress that unlicensed cannabis-based medicinal products should not circumvent usual regulatory requirements before being prescribed.
They also worry that children with epilepsy are at risk of being used as a “Trojan horse” for the cannabis industry, with widespread acceptance of medicinal cannabis accelerating the wider legalization of marijuana and opening up a highly lucrative commercial market.
Source: Medindia
Advertisement
Source:
